MAPT and Alzheimer disease: Accordingly, brain amyloid burden or cerebrospinal fluid (CSF) levels of phosphorylated-tau (P-tau) and total-tau (T-tau) presented similar alterations among AD patients with and without OSA after 2.52 ± 0.51 years of follow-up [17].